Trial intelligence / Profile preview

EEG detection of attempted movement during temporary arm paralysis in healthy volunteers

NL-OMON35619Withdrawn

Sponsor
Radboud University Medical Center
Start
Jan 2012
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Open-label, single-arm trial of rocuronium and Sugammadex, sponsored by Radboud University Medical Center. Primary endpoints: Classification rate of the EEG algorithm and Event-related desynchronization and synchronization features. Planned start Jan 2012; status: withdrawn.

02

Drugs

rocuroniumSugammadex

Beyond the preview

Go deeper on NL-OMON35619.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON35619.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call